CN Patent

CN116261451A — γ-羟基丁酸衍生物的药物组合物和药物动力学

Assigned to Kairui Corning Biological Engineering Co ltd · Expires 2023-06-13 · 3y expired

What this patent protects

本发明公开4‑((L‑缬氨酰基)氧基)丁酸的药物组合物和在向健康受试者经口施用所述药物组合物之后4‑((L‑缬氨酰基)氧基)丁酸和γ‑羟基丁酸的药物动力学。

USPTO Abstract

本发明公开4‑((L‑缬氨酰基)氧基)丁酸的药物组合物和在向健康受试者经口施用所述药物组合物之后4‑((L‑缬氨酰基)氧基)丁酸和γ‑羟基丁酸的药物动力学。

Drugs covered by this patent

Patent Metadata

Patent number: CN116261451A
Jurisdiction: CN
Classification: —
Expires: 2023-06-13
Drug substance claim: No
Drug product claim: No
Assignee: Kairui Corning Biological Engineering Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.